A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum
NCT07337564 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2026-01-13
Summary
This study was designed to assess the therapeutic efficacy and safety of SHR-1139 Injection in adult patients with ulcerative pyoderma gangrenosum.
Conditions
- Pyoderma Gangrenosum
Interventions
- DRUG
-
SHR-1139 Injection
SHR-1139 Injection
Sponsors & Collaborators
-
Shandong First Medical University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-01
- Primary Completion
- 2027-12-31
- Completion
- 2028-06-30
Countries
- China
Study Locations
More Related Trials
-
Eschar Investigations in Scrub Typhus
NCT02915861 ·Status: COMPLETED
-
Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases
NCT06666153 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Phage Therapy for the Prevention and Treatment of Pressure Ulcers.
NCT04815798 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
NCT02281643 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy Participants
NCT04301310 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase I Study of XJ101 in Chinese Healthy Subjects
NCT06014736 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely
NCT00368498 ·Status: UNKNOWN ·Phase: PHASE4
-
A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan
NCT04459507 ·Status: COMPLETED
-
Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
NCT01138956 ·Status: UNKNOWN ·Phase: NA
-
Timing of Surgical Intervention in Buruli Ulcer Patients Treated With Antibiotics
NCT01432925 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating Efficacy and Safety of CRO-SBT in the Treatment of Gonorrhea
NCT04202068 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety of Daptomycin in the Treatment of Gram-positive Bacterial Infection.
NCT04546815 ·Status: UNKNOWN
-
Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge
NCT01222832 ·Status: COMPLETED ·Phase: PHASE2
-
An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)
NCT02365623 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of MRSA Polymerase Chain Reaction for Pneumonia
NCT02660554 ·Status: COMPLETED ·Phase: NA
-
Identification of the Cutaneous Microbiota in Patients With Cutaneous Infection (MICROBIOTA)
NCT03985475 ·Status: UNKNOWN
-
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
NCT05177107 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria
NCT01311154 ·Status: UNKNOWN
-
Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.
NCT02357966 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Efficacy and Safety of Bedaquiline (TMC207) in Participants With Multibacillary Leprosy
NCT03384641 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Detection of Staphylococcus Aureus in Burn Patients
NCT01140269 ·Status: COMPLETED ·Phase: NA
-
PK/PD of Ertapenem In Patients With TB
NCT01730664 ·Status: COMPLETED ·Phase: PHASE2
-
Uniform Multidrug Therapy Regimen for Leprosy Patients
NCT00669643 ·Status: COMPLETED ·Phase: PHASE4
-
The Clinical Trial of Cefuroxime Axetil Dispersible Tablets
NCT03020940 ·Status: UNKNOWN
-
Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis
NCT01169038 ·Status: COMPLETED ·Phase: PHASE1